NCT00267176View on ClinicalTrials.gov

Safety and Efficacy of Lumiracoxib in Patients With Osteoarthritis and With Controlled Hypertension

PHASE4CompletedINTERVENTIONAL
Enrollment

1,020

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

September 30, 2006

Conditions
OsteoarthritisControlled Hypertension
Interventions
DRUG

lumiracoxib

Trial Locations (2)

62269

Southern Illinois Clinical Research, O'Fallon

Unknown

Novartis, Nuremberg

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY